Scientists reveal another piece in the long COVID puzzle
In patients with long COVID, a new study has revealed a structural association between circulating microclots and neutrophil extracellular traps (NETs).
Medical Xpress
Unique immune signatures can distinguish rare autoimmune condition from multiple sclerosis
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a rare autoimmune condition in which the body’s immune system mistakenly attacks the protective myelin sheath of nerve fibers in the central nervous system. Although MOGAD induc…
New immune response patterns for tuberculosis discovered outside the lungs
Tuberculosis (TB) is one of the world’s most common infectious diseases. Although infection with the Mycobacterium tuberculosis bacterium primarily affects the lungs, up to 25% of all infected people will also have it in other parts of their bodies, su…
Largest study on infant-type hemispheric glioma reports factors to guide treatment approaches
Clinician-scientists at St. Jude Children’s Research Hospital and collaborators have conducted the largest study of infant-type hemispheric glioma (IHG) ever reported, uncovering key factors that could be used to guide treatment strategies for this rar…
Factoring in frailty and age could improve pancreatic cancer treatment
While some risk factors for cancer can be mitigated through lifestyle choices such as diet or exercise, aging is not one of them. In the case of pancreatic cancer, it also can limit treatment options if a patient is too frail to be safely treated with …
What is myasthenia gravis, the rare disease tennis great Monica Seles lives with?
Former tennis star Monica Seles recently revealed she is living with the rare disease myasthenia gravis, which affects 12 in 100,000 people globally.
HER2-targeted radioimmunotherapy regimen achieves complete and durable response in breast cancer model
A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 (HER2)-positive breast cancer, according to new research published in the November issue of The Journal of Nuclear Medicine. The regimen, which pre-tre…
Combination immunotherapy helps overcome melanoma treatment resistance
Early data from a Phase 2 clinical trial show a combination of immunotherapy medications can activate a robust immune response and help overcome treatment resistance in patients with refractory melanoma.
Early HIV drugs give immune system a brief reprieve before dysregulation returns, study finds
Despite effective HIV medication, the immune system of people with HIV remains disrupted in the long term.
A toast to BRD4: How acidity changes the immune response
It started with wine. Or more precisely, a conversation about it. “My colleagues and I were talking about how some people think drinking wine may be anti-inflammatory,” recalls Xu Zhou, Ph.D., from the Division of Gastroenterology, Hepatology, and Nutr…